Table 5.
Relation between QR of methylated 3-OST-2 and tumor stage
| Stage I | Stage II | Stage III | Stage IV | Stages II–IV |
|---|---|---|---|---|
| 1.36 | 5.74 | 7.9 | 68.39 | 5.74 |
| 18.26 | 97.72 | 316.23 | 114.81 | 97.72 |
| 4 | 758 | 15.49 | 758 | |
| 3.1 | 18.62 | 975 | 18.62 | |
| 4.37 | 12.88 | 219.7 | 12.88 | |
| 1.89 | 45.1 | 501.2 | 45.1 | |
| 0 | 37.16 | 35.48 | 37.16 | |
| 1.7 | 776.28 | 38.9 | 776.28 | |
| 0 | 93.33 | 169.8 | 93.33 | |
| 7.32 | 0 | 5.37 | 0 | |
| 1.2 | 1 | 1 | ||
| 0.6 | 0 | 0 | ||
| 3.21 | 7.9 | |||
| 36.98 | 316.23 | |||
| 3.5 | 15.49 | |||
| 975 | ||||
| 219.7 | ||||
| 501.2 | ||||
| 35.48 | ||||
| 38.9 | ||||
| 169.8 | ||||
| 5.37 | ||||
| 68.39 | ||||
| 114.81 | ||||
| Mean | ||||
| 5.8 | 153.8 | 228.5 | 179.7 | |
Mann–Whitney U-test P<0.05. Stage I vs. stage II P=0.0315, stage I vs. stage III P=0.0002, stage I vs. stages II–IV P=0.0003. For one NSCLC stage was not known.